Current concepts in eosinophilic esophagitis.
Options
BORIS DOI
Date of Publication
2017
Publication Type
Article
Division/Institute
Contributor
Straumann, Alex | |
Schoepfer, Alain M |
Subject(s)
Series
Allergo journal international
ISSN or ISBN (if monograph)
2197-0378
Publisher
Springer
Language
English
Publisher DOI
PubMed ID
29104849
Uncontrolled Keywords
Description
Background
Eosinophilic esophagitis (EoE) is a disease entity first described in the 1990s, but showing an increasing incidence that is characterized clinically by esophageal dysfunction and histologically by a striking eosinophil infiltration.
Methods
This article discusses new aspects of the pathogenesis, symptoms, diagnosis, and treatment of EoE.
Results
EoE affects both children and adults and is frequently associated with atopic disease and IgE sensitization. Barrier dysfunction and T‑helper 2 inflammation are considered to be pathogenetically important factors. Recently, a proton pump inhibitor (PPI)-sensitive EoE subtype as well as an EoE-like disorder have been described.
Conclusion
Research in recent years has contributed to a better understanding of the disease spectrum and pathogenesis of EoE, including genetic dispositions, thereby laying the foundation for innovative treatment approaches.
Eosinophilic esophagitis (EoE) is a disease entity first described in the 1990s, but showing an increasing incidence that is characterized clinically by esophageal dysfunction and histologically by a striking eosinophil infiltration.
Methods
This article discusses new aspects of the pathogenesis, symptoms, diagnosis, and treatment of EoE.
Results
EoE affects both children and adults and is frequently associated with atopic disease and IgE sensitization. Barrier dysfunction and T‑helper 2 inflammation are considered to be pathogenetically important factors. Recently, a proton pump inhibitor (PPI)-sensitive EoE subtype as well as an EoE-like disorder have been described.
Conclusion
Research in recent years has contributed to a better understanding of the disease spectrum and pathogenesis of EoE, including genetic dispositions, thereby laying the foundation for innovative treatment approaches.
File(s)
| File | File Type | Format | Size | License | Publisher/Copright statement | Content | |
|---|---|---|---|---|---|---|---|
| 40629_2017_Article_37.pdf | text | Adobe PDF | 846.28 KB | Attribution (CC BY 4.0) | published |